Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 21.12
-0.38 (-1.77%)
Sep 10, 2026, 1:14 PM CST
SHE:300702 Revenue
Zhejiang Tianyu Pharmaceutical had revenue of 1.20B CNY in the quarter ending June 30, 2026, with 48.38% growth. This brings the company's revenue in the last twelve months to 3.50B, up 19.49% year-over-year. In the year 2025, Zhejiang Tianyu Pharmaceutical had annual revenue of 3.06B with 16.36% growth.
Revenue (ttm)
3.50B
Revenue Growth
+19.49%
P/S Ratio
2.11
Revenue / Employee
747.85K
Employees
4,686
Market Cap
7.39B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.06B | 430.33M | 16.36% |
| Dec 31, 2024 | 2.63B | 103.54M | 4.10% |
| Dec 31, 2023 | 2.53B | -139.41M | -5.23% |
| Jan 1, 2023 | 2.67B | 121.67M | 4.78% |
| Jan 1, 2022 | 2.55B | -42.39M | -1.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 9.93B |
| China Animal Husbandry Industry | 6.58B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Jiuzhitang | 2.60B |
| Hubei Hongyuan Pharmaceutical Technology | 2.40B |
| Guilin Sanjin Pharmaceutical | 2.02B |
| Guangxi Wuzhou Zhongheng Group | 1.24B |
| Sichuan Huiyu Pharmaceutical | 1.10B |